Infarct-Limiting Efficacy of KATP Channel Activators and Nitric Oxide Donors under Conditions of Their Chronic Administration and Diet-Induced Metabolic Syndrome Conditions in Rats
Crossref DOI link: https://doi.org/10.1007/s10517-025-06421-y
Published Online: 2025-07-18
Published Print: 2025-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Naryzhnaya, N. V.
Mukhomedzyanov, A. V.
Kilin, M.
Voronkov, N. S.
Kurbatov, B. K.
Maslov, L. N.
Text and Data Mining valid from 2025-05-01
Version of Record valid from 2025-05-01
Article History
Received: 21 August 2024
First Online: 18 July 2025